The federal judge in Trenton overseeing multidistrict litigation over allegedly improper marketing of blood pressure drug Plavix has granted motions by defendants Bristol-Myers Squibb and Sanofi-Aventis U.S. to dismiss the majority of claims in a False Claims Act case related to the drug.
U.S. District Judge Freda Wolfson of the District of New Jersey dismissed claims under the False Claims Act related to Medicare Part D and the Medicare plans of 33 states, as well as claims based on state formularies. Also dismissed were state law claims based on the laws of 43 states. The judge declined to dismiss FCA claims for 17 states, and state law claims for seven states.
